RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Shineway Pharmaceutical Group Stock

China Shineway Pharmaceutical Group EBIT 2024

China Shineway Pharmaceutical Group EBIT

1.33 B CNY

Ticker

2877.HK

ISIN

KYG2110P1000

WKN

A0DNLW

In 2024, China Shineway Pharmaceutical Group's EBIT was 1.33 B CNY, a 17.54% increase from the 1.13 B CNY EBIT recorded in the previous year.

The China Shineway Pharmaceutical Group EBIT history

YEAREBIT (undefined CNY)
2026e1.77
2025e1.53
2024e1.33
20231.13
20220.83
20210.64
20200.52
20190.56
20180.53
20170.49
20160.59
20150.7
20140.76
20130.78
20120.72
20110.88
20100.94
20090.71
20080.58
20070.43
20060.34
20050.34
20040.28

China Shineway Pharmaceutical Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Shineway Pharmaceutical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Shineway Pharmaceutical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Shineway Pharmaceutical Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Shineway Pharmaceutical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Shineway Pharmaceutical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Shineway Pharmaceutical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Shineway Pharmaceutical Group’s growth potential.

China Shineway Pharmaceutical Group Revenue, EBIT and net profit per share

DateChina Shineway Pharmaceutical Group RevenueChina Shineway Pharmaceutical Group EBITChina Shineway Pharmaceutical Group Net Income
2026e6.85 B undefined1.77 B undefined1.43 B undefined
2025e5.96 B undefined1.53 B undefined1.25 B undefined
2024e5.19 B undefined1.33 B undefined1.1 B undefined
20234.52 B undefined1.13 B undefined969.51 M undefined
20223.95 B undefined826.94 M undefined722.77 M undefined
20213.22 B undefined636.59 M undefined556.67 M undefined
20202.66 B undefined515.05 M undefined295.03 M undefined
20192.71 B undefined562.48 M undefined503.15 M undefined
20182.57 B undefined533.07 M undefined505.88 M undefined
20171.92 B undefined487.25 M undefined451.55 M undefined
20161.99 B undefined588.29 M undefined589.2 M undefined
20152.05 B undefined697.97 M undefined657.91 M undefined
20142.23 B undefined755.68 M undefined704.78 M undefined
20132.19 B undefined775.5 M undefined683.6 M undefined
20122.13 B undefined724.1 M undefined647.7 M undefined
20111.98 B undefined883.8 M undefined755.6 M undefined
20102.04 B undefined943.8 M undefined821.8 M undefined
20091.63 B undefined712.5 M undefined767.3 M undefined
20081.28 B undefined575.3 M undefined398.2 M undefined
20071.01 B undefined425.6 M undefined490.6 M undefined
2006841.5 M undefined342.2 M undefined333 M undefined
2005831.4 M undefined342.5 M undefined331.5 M undefined
2004703.6 M undefined280.8 M undefined260.8 M undefined

China Shineway Pharmaceutical Group stock margins

The China Shineway Pharmaceutical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Shineway Pharmaceutical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Shineway Pharmaceutical Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Shineway Pharmaceutical Group's sales revenue. A higher gross margin percentage indicates that the China Shineway Pharmaceutical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Shineway Pharmaceutical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Shineway Pharmaceutical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Shineway Pharmaceutical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Shineway Pharmaceutical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Shineway Pharmaceutical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Shineway Pharmaceutical Group Margin History

China Shineway Pharmaceutical Group Gross marginChina Shineway Pharmaceutical Group Profit marginChina Shineway Pharmaceutical Group EBIT marginChina Shineway Pharmaceutical Group Profit margin
2026e75.15 %25.77 %20.91 %
2025e75.15 %25.6 %20.92 %
2024e75.15 %25.68 %21.18 %
202375.15 %25.09 %21.47 %
202274.38 %20.93 %18.3 %
202174.77 %19.75 %17.27 %
202074.85 %19.39 %11.11 %
201973.23 %20.79 %18.59 %
201872.99 %20.74 %19.68 %
201766.01 %25.38 %23.52 %
201664.54 %29.51 %29.56 %
201566.23 %33.97 %32.02 %
201466.3 %33.9 %31.62 %
201367.41 %35.46 %31.26 %
201265.28 %33.96 %30.38 %
201165.61 %44.54 %38.08 %
201070.4 %46.3 %40.32 %
200972.13 %43.63 %46.98 %
200871.7 %45.11 %31.23 %
200772.86 %42.02 %48.44 %
200670.39 %40.67 %39.57 %
200566.95 %41.2 %39.87 %
200464.18 %39.91 %37.07 %

China Shineway Pharmaceutical Group Aktienanalyse

What does China Shineway Pharmaceutical Group do?

China Shineway Pharmaceutical Group Ltd was founded in 1996 and has since become one of the leading Chinese pharmaceutical companies. Based in Beijing, the company offers a wide range of products in various segments, including traditional Chinese medicine, Western medicine, and health products. China Shineway's business model is based on research and development, production, distribution, and marketing of pharmaceutical products. The company strives to advance the development of new drugs and treatment methods by continuously improving its research and development department. The company covers various areas of healthcare, including the manufacturing of remedies for cancer, cardiovascular diseases, orthopedic surgery, and neurology. China Shineway also specializes in the development of herbal medicines for use in traditional Chinese medicine. The company has thus occupied a niche market and is an important provider of natural remedies for various health needs in this niche. Another important aspect of Shineway's business is the production of raw materials for use in other pharmaceutical products. The company has a strong presence in the Chinese market and supplies other companies with pharmaceutical raw materials for drug manufacturing. The company continuously improves its production capacity and implements new technologies for the production of high-quality goods. One of the most well-known products in traditional Chinese medicine at Shineway is Naoxintong. Naoxintong is an herbal medicine used for the treatment of cardiovascular diseases and helps to lower cholesterol levels and blood pressure. The combination of natural plant extracts is unique and has found great demand in China. Another product segment of China Shineway is the business of health products. The company offers high-quality dietary supplements, vitamins, and minerals to improve overall well-being and physical health. The company is committed to ensuring the highest level of quality and safety in all its products. The company also operates a strong international business by exporting its products worldwide. China Shineway has branches in several countries, including Europe, Africa, and Asia, creating access to global markets. Due to the high demand for natural remedies in traditional Chinese medicine, the company has made significant progress in international markets in recent years. China Shineway also has a strong social responsibility and supports numerous charitable and nonprofit organizations in China. The company has launched a donation initiative and distributed medicines and health products for free to those who could not afford them. It is also committed to protecting the environment and invests in environmentally friendly technologies to reduce its carbon footprint. Overall, China Shineway has established itself as an important company in the Chinese pharmaceutical industry and has managed to be successful both internationally and in the domestic market. The company is committed to continuing its commitment to research and development to provide even better drugs and treatment methods in the future. China Shineway Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing China Shineway Pharmaceutical Group's EBIT

China Shineway Pharmaceutical Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of China Shineway Pharmaceutical Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

China Shineway Pharmaceutical Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in China Shineway Pharmaceutical Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about China Shineway Pharmaceutical Group stock

How much did China Shineway Pharmaceutical Group achieve in EBIT for the current year?

In the current year, China Shineway Pharmaceutical Group has achieved an EBIT of 1.33 B CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company China Shineway Pharmaceutical Group.

How has the EBIT of China Shineway Pharmaceutical Group developed in recent years?

The EBIT of China Shineway Pharmaceutical Group has increased by 17.537% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company China Shineway Pharmaceutical Group?

The EBIT of China Shineway Pharmaceutical Group is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does China Shineway Pharmaceutical Group pay?

Over the past 12 months, China Shineway Pharmaceutical Group paid a dividend of 0.47 CNY . This corresponds to a dividend yield of about 6.49 %. For the coming 12 months, China Shineway Pharmaceutical Group is expected to pay a dividend of 0.49 CNY.

What is the dividend yield of China Shineway Pharmaceutical Group?

The current dividend yield of China Shineway Pharmaceutical Group is 6.49 %.

When does China Shineway Pharmaceutical Group pay dividends?

China Shineway Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, May, June, October.

How secure is the dividend of China Shineway Pharmaceutical Group?

China Shineway Pharmaceutical Group paid dividends every year for the past 22 years.

What is the dividend of China Shineway Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.49 CNY are expected. This corresponds to a dividend yield of 6.81 %.

In which sector is China Shineway Pharmaceutical Group located?

China Shineway Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Shineway Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Shineway Pharmaceutical Group from 9/27/2024 amounting to 0.12 CNY, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did China Shineway Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of China Shineway Pharmaceutical Group in the year 2023?

In the year 2023, China Shineway Pharmaceutical Group distributed 0.383 CNY as dividends.

In which currency does China Shineway Pharmaceutical Group pay out the dividend?

The dividends of China Shineway Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Shineway Pharmaceutical Group

Our stock analysis for China Shineway Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Shineway Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.